PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Renal Transplant Center, Sheba Medical Center, Tel Hashomer, Israel.\', \'Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.\', \'Bio-statistical and Bio-mathematical Unit, The Gertner Institute of Epidemiology and Health Policy Research, Sheba Medical Center, Tel Hashomer, Israel.\', \'The Infectious Diseases Unit, Sheba Medical Center, Tel Hashomer, Israel.\', \'Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center, Tel-Hashomer, Israel.\', \'Internal Medicine Wing, Sheba Medical Center, Tel Hashomer, Israel.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.3389/ti.2022.10239
?:hasPublicationType
?:journal
  • Transplant international : official journal of the European Society for Organ Transplantation
is ?:pmid of
?:pmid
?:pmid
  • 35387393
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • BNT162b2 Third Booster Dose Significantly Increases the Humoral Response Assessed by Both RBD IgG and Neutralizing Antibodies in Renal Transplant Recipients.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all